Inhibition of EphA2 by inhibitors, conjugated peptides or agonistic antibody is sufficient to induce tumor cell death and inhibit tumor growth [9, 10]; however, several studies have also identified EphA2 as tumor suppressor [13–15]. This evidence concerns the gene EPHA2 and neoplasm.